By proceeding, you agree to our Terms of Use and Privacy Policy.
Welcome to the Next Generation Kinase Inhibitors Summit – the Future of Targeted Therapies Kinase inhibitors have proven to be efficacious and approvable targets, fueling recent investment into this exciting space as their therapeutic targeting is explored beyond oncology.
The summit boasts of 20+ Speakers from world-class organizations like AstraZeneca, GlaxoSmithKline, Rigel Pharmaceuticals, AUM Biosciences, amongst others.
Know how to target the undruggable, elevate drug design for enhanced target selectivity, overcome the blood brain barrier etc. using Kinase Inhibitor Therapies.
Participate in the exclusive and insightful Workshop - that will drive stimulating discussions on applying Kinase Biology for Drug Development.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
AssayQuant® mission is to support the development of more effective therapies for cancer, chronic inflammation, neurodegeneration, and other serious conditions.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.